We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
MIRA Pharmaceuticals Inc | NASDAQ:MIRA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -1.41% | 0.70 | 0.70 | 0.725 | 0.72 | 0.70 | 0.71 | 25,630 | 16:10:18 |
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Brian McNulty, Individually and as Trustee of the Bay Shore Trust
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☐
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
OO
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☐
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
United States of America
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
10,000
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
5,338,365
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
10,000
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
5,338,365
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
5,348,365 (1)
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
32.45% (2)
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
IN
|
|
|
|||
|
|
(1)
|
Consists of 4,559,318 shares of common stock, par value $0.0001 per share (the “Common Stock”) beneficially owned in the manner described below by the Bay Shore Trust, of which Brian
McNulty is trustee; 779,047 shares of Common Stock beneficially owned by another trust of which Brian McNulty is trustee; and 10,000 shares of Common Stock directly held by Brian McNulty.
|
(2)
|
Based on 14,780,885 shares of Common Stock of the Issuer outstanding as of November 13, 2023, as disclosed in the Issuer’s Periodic Report on Form 10-Q (the “Form 10-Q”), which was
filed with the Securities and Exchange Commission (the “SEC”) on November 13, 2023.
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Bay Shore Trust
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☐
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
OO
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☐
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
United States of America
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
4,559,318
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
4,559,318
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
4,559,318
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
27.66% (1)
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
IN
|
|
|
|||
|
|
(1)
|
Based on 14,780,885 shares of Common Stock of the Issuer outstanding as of November 13, 2023, as disclosed in the Form 10-Q.
|
Item 1.
|
Security and Issuer
|
Item 2.
|
Identity and Background
|
(a)
|
This Amendment is being filed jointly by (1) McNulty, individually and in his capacity as trustee of Bay Shore Trust; and (2) the Trust. The joint filing agreement of the Reporting Persons is incorporated
herein by reference to Exhibit 99.1 to the Schedule 13D/A filed by the Reporting Persons on October 12, 2023.
|
(b)
|
The principal business address of the Reporting Persons is 855 N Wolfe Street, Suite 601, Baltimore, Maryland 21205.
|
(c)
|
The principal business of McNulty is business owner and sports coaching. The principal occupation of the Trust is to administer the assets of
the Trust for the benefit of the beneficiaries thereof.
|
(d)-(e)
|
During the last five years, none of the Reporting Persons (i) has been convicted in a criminal proceeding (excluding traffic violations or
similar misdemeanors) or (ii) has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceedings was or is subject to a judgment, decree, or final order enjoining
future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violations with respect at such laws.
|
(f)
|
McNulty is a citizen of the United States.
|
Item 3.
|
Source and Amount of Funds or Other Consideration
|
Item 4.
|
Purpose of Transaction
|
Item 5.
|
Interest in Securities of the Company
|
(a)-(b)
|
As of the date of this Amendment, Trust beneficially owns 4,559,318 shares of Company Common Stock, which represents 27.66% of the Company Common Stock as of
the date hereof and which is comprised of 2,859,318 outstanding shares of Common Stock, 1,000,000 shares of Common Stock issuable upon the exercise of a warrant held by the Trust, and the warrant to purchase 700,000 shares of Common
Stock acquired by MIRALOGX on November 15, 2023. McNulty is the sole trustee of the Trust, and by virtue of such relationship, McNulty is deemed to have shared voting and investment power with respect to the Company Common Stock
held by the Trust. Individually, McNulty holds and has sole voting and dispositive power over 10,000 shares of Company Common Stock, which represents 0.07% of the Company Common Stock as of the date hereof, and together with the
shares held by Trust and another trust of which McNulty is the sole trustee, McNulty has shared dispositive power over 5,338,365 shares of Company Common Stock, which represents 32.39% of the Company Common Stock as of the date
hereof. In the aggregate, McNulty beneficially owns 5,348,365 shares of Company Common Stock, which represents 32.45% of the Company Common Stock as of the date hereof.
|
(c)
|
Except as described in this Amendment, including in Item 3, there have been no transactions in the shares of Company Common Stock effected by
the Reporting Persons during the last 60 days.
|
(d)
|
To the best knowledge of the Reporting Persons, none of the Reporting Persons has or knows any other person who has the right to receive or the power to
direct the receipt of dividends from, or the proceeds from the sale of, and Company Common Stock beneficially owned by the Reporting Persons.
|
(e)
|
Not applicable.
|
Item 6.
|
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Company
|
Item 7.
|
Material to be Filed as Exhibits
|
Exhibit No.
|
Description
|
|
|
99.1
|
Joint Filing Agreement among the Reporting Persons, dated as of October 12, 2023, and incorporated by reference to the Schedule 13D/A filed on such date by the Reporting Persons.
|
BAY SHORE TRUST
By: /s/ Brian McNulty
Brian McNulty, Trustee of the Bay Shore Trust
|
/s/ Brian McNulty
Brian McNulty
|
1 Year MIRA Pharmaceuticals Chart |
1 Month MIRA Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions